Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Later line chemotherapy causes severe side effects, impacting quality of life, but patients continue treatment to extend life and stay connected with loved ones.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

The hydrogels show promise for targeted cervical cancer treatment but need more testing.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Tofacitinib taken by mouth helps treat hair loss in children.